Last edition
News about "Pebrilzo pertuzumab biosimilar"
Biocon Secures Early Launch Dates for Pebrilzo Biosimilar
Biocon has secured the earliest licensed launch dates for Pebrilzo (bPertuzumab) following global patent settlement with Genentech.
Pebrilzo Pertuzumab Biosimilar | 14/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members